The use of topical corticosteroids in the treatment of persistent allergic rhinitis
https://doi.org/10.21518/2079-701X-2014-15-78-80
Abstract
Persistent (year-round) allergic rhinitis is one of the most pressing global health problems characterized by a steady growth in the number of patients in every country, including Russia. The disease has a dramatic impact on the quality of life, while the economic cost of the fight against allergic rhinitis and its complications is a significant financial burden. Topical corticosteroids are the treatment of choice in patients with persistent allergic rhinitis.
About the Authors
I. L. Lazarevich
Teaching and Research Medical Center of the Russian Federation Presidential Administration
Russian Federation
Russian Federation
V. S. Kozlov
Teaching and Research Medical Center of the Russian Federation Presidential Administration
Russian Federation
Russian Federation
References
1. Ильина Н.И. Эпидемиология аллергического ринита. Российская ринология, 1999, 1: 23-25.
2. Лопатин А.С., Гущин И.С., Емельянов А.В. и др. Consilium medicum, 2001. Приложение. 33-44.
3. Мокроносова М.А. Влияние назального спрея флутиказона пропионата на симптомы аллергического персистирующего ринита и эозинофилию назального секрета. Фарматека, 2004, 12: 11-12.
4. Bousquet J, van Cavuwenberge P, Khaltaev N et al. Allergic rhinitis and its impact on asthma (ARIA). Pocket Guide-WHO, 2001.
5. Bousquet J, Khaltaev N, Cruz A et al. Allergic rhinitis and its impact on asthma (ARIA) update 2008 (in collaboration with World Health Organization, GA2LEN and AllerGen). Allergy, 2008, 63 (suppl. 86): 8-160.
6. Hellgren J, Cervin A, Nordling S, Bergman A, Cardell LO. Allergic rhinitis and the common cold - high cost to society. Allergy, 2009, epub DOI: 10.1111/j.1398-9995.2009.02269.x.
7. Жерносек В.Ф. Новые возможности лечения аллергического ринита. Медицинские новости, 2011, 5: 26-30.
8. Жерносек В.Ф., Дюбкова Т.П. Аллергические заболевания у детей: Рук. для врачей. Минск, 2003.
9. Allergic rhinitis and its impact on asthma (ARIA) 2010 Update (in collaboration with World Health Organization, GA2LEN and AllerGen). Allergy, 2010 (Suppl. 86): 8-160.
10. Егорова О.А. Интраназальный глюкокортикостероид флутиказона пропионат (Назарел) в лечении аллергического ринита. Атмосфера. Пульмонология и аллергология, 2010, 1: 40-44.
11. Keith PK et al.Ann. Allergy Asthma Immunol, 2009, 103 (6): 539.
12. Jacobs RL. et al. Allergy Asthma Proc, 2002, 23 (4): 259.
13. Yamamoto H et al. Comparison of nasal steroid with antihistamine in prophylactic treatment against polli-nosis using an environmental challenge chamber. Allergy Asthma Proc., 2012, Sep.-Oct., 33 (5): 397-403.
Review
For citations:
Lazarevich IL, Kozlov VS. The use of topical corticosteroids in the treatment of persistent allergic rhinitis. Meditsinskiy sovet = Medical Council. 2014;(15):78-80. (In Russ.) https://doi.org/10.21518/2079-701X-2014-15-78-80
Views:
472
Email this article 